Correlation Between Lion Biotechnologies and DOCDATA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lion Biotechnologies and DOCDATA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lion Biotechnologies and DOCDATA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lion Biotechnologies and DOCDATA, you can compare the effects of market volatilities on Lion Biotechnologies and DOCDATA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lion Biotechnologies with a short position of DOCDATA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lion Biotechnologies and DOCDATA.

Diversification Opportunities for Lion Biotechnologies and DOCDATA

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Lion and DOCDATA is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Lion Biotechnologies and DOCDATA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DOCDATA and Lion Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lion Biotechnologies are associated (or correlated) with DOCDATA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DOCDATA has no effect on the direction of Lion Biotechnologies i.e., Lion Biotechnologies and DOCDATA go up and down completely randomly.

Pair Corralation between Lion Biotechnologies and DOCDATA

Assuming the 90 days trading horizon Lion Biotechnologies is expected to generate 1.28 times more return on investment than DOCDATA. However, Lion Biotechnologies is 1.28 times more volatile than DOCDATA. It trades about -0.05 of its potential returns per unit of risk. DOCDATA is currently generating about -0.09 per unit of risk. If you would invest  891.00  in Lion Biotechnologies on September 15, 2024 and sell it today you would lose (150.00) from holding Lion Biotechnologies or give up 16.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Lion Biotechnologies  vs.  DOCDATA

 Performance 
       Timeline  
Lion Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lion Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
DOCDATA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DOCDATA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Lion Biotechnologies and DOCDATA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lion Biotechnologies and DOCDATA

The main advantage of trading using opposite Lion Biotechnologies and DOCDATA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lion Biotechnologies position performs unexpectedly, DOCDATA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DOCDATA will offset losses from the drop in DOCDATA's long position.
The idea behind Lion Biotechnologies and DOCDATA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements